Search

Alveolar bone defects (ABDs) were a perennial problem, especially in the aged. Bisphosphonates, especially etidronate sodium (ET), were frequently used in clinical treatment of ABD. However, the oral administration of ET had poor absorption (<1%). Therefore, optimization of a suitable dosage form substituted with ET to locally repair the ABD was a straightforward approach. Polylactide-co-glycolide (PLGA) is a biodegradable material and had been used in locally implanted medical devices. Therefore, an ET-PLGA microcapsule may help local delivery and prolong the activity of healing ABD. In this paper, a preparation method of ET-PLGA microcapsule was optimized by the single-factor investigation and response surface method. Subsequently, the rat ABD model was used to evaluate the enhancement effect of these microcapsules. Finally, the optimum parameters were determined as follows: 40% dichloromethane, 160 mg/mL PLGA, 10% internal aqua/oil phase, 4% PVA, and emulsifying for 10 min. These microcapsules were spherical in shape and fairly monodisperse in a particle size of 27,51 μm (PDI = 0.3), encapsulation rate 96.6%, and drug loading 4.58%. Compared with the ET groups, the total healing volume of ABD in ET-PLGA groups was significantly increased P < 0.05 . ET-PLGA microcapsules significantly enhanced the effect of ET on ABD. This study provided important technical support for the treatment of ABD with bisphosphonates by local administration. This paper has an exploratory significance for the development of water-soluble bioactive components with low bioavailability for ABD. [ABSTRACT FROM AUTHOR]

The antioxidant activity of protein-derived peptides was one of the first to be revealed among the more than 50 known peptide bioactivities to date. The exploitation value associated with food-derived antioxidant peptides is mainly attributed to their natural properties and effectiveness as food preservatives and in disease prevention, management, and treatment. An increasing number of antioxidant active peptides have been identified from a variety of renewable sources, including terrestrial and aquatic organisms and their processing by-products. This has important implications for alleviating population pressure, avoiding environmental problems, and promoting a sustainable shift in consumption. To identify such opportunities, we conducted a systematic literature review of recent research advances in food-derived antioxidant peptides, with particular reference to their biological effects, mechanisms, digestive stability, and bioaccessibility. In this review, 515 potentially relevant papers were identified from a preliminary search of the academic databases PubMed, Google Scholar, and Scopus. After removing non-thematic articles, articles without full text, and other quality-related factors, 52 review articles and 122 full research papers remained for analysis and reference. The findings highlighted chemical and biological evidence for a wide range of edible species as a source of precursor proteins for antioxidant-active peptides. Food-derived antioxidant peptides reduce the production of reactive oxygen species, besides activating endogenous antioxidant defense systems in cellular and animal models. The intestinal absorption and metabolism of such peptides were elucidated by using cellular models. Protein hydrolysates (peptides) are promising ingredients with enhanced nutritional, functional, and organoleptic properties of foods, not only as a natural alternative to synthetic antioxidants. [ABSTRACT FROM AUTHOR]

This paper reports various types of cancer, their incidence, and prevalence all over the globe. Along with the discovery of novel natural drugs for cancer treatment, these present a promising option which are eco-friendly, safe, and provide better acceptability in comparison to synthetic agents that carries multiple side effects. This paper provides an idea about various nanocarriers and phytochemicals, along with how their solubility and bioavailability can be enhanced in nanocarrier system. This report combines the data from various literature available on public domain including PubMed on research articles, reviews, and along with report from various national and international sites. Specialized metabolites (polyphenols, alkaloids, and steroids etc) from medicinal plants are promising alternatives to existing drugs. Studies have suggested that the treatment of cancer using plant products could be an alternative and a safe option. Studies have shown with the several cell lines as well as animal models, that phytomolecules are important in preventing/treating cancer. Phytochemicals often outperform chemical treatments by modulating a diverse array of cellular signaling pathways, promoting cell cycle arrest, apoptosis activation, and metastatic suppression, among others. However, limited water solubility, bioavailability, and cell penetration limit their potential clinical manifestations. The development of plant extract loaded nanostructures, rendering improved specificity and efficacy at lower concentrations could prove effective. Nanocarriers, such as liposomes, nanostructured lipids, polymers, and metal nanoparticles, have been tested for the delivery of plant products with enhanced effects. Recent advances have achieved improvement in the the stability, solubility, bioavailability, circulation time, and target specificity by nanostructure-mediated delivery of phytochemicals. Nanoparticles have been considered and attempted as a novel, targeted, and safe option. Newer approaches such as phyto-nanocarriers with carbohydrates, lignin, and polymers have been considered even more selective and effective modes of drug delivery in biomedical or diagnostic applications. [ABSTRACT FROM AUTHOR]

Background and Objectives: Iron is an essential micronutrient for many biological functions and has been found to be intimately linked to cancer biology. Although the effects of increased dietary iron consumption in the development of CRC have been previously investigated in several cohort studies, the available evidence on the involvement of iron deficiency in this process is relatively scarce. Previously published papers did not analyze specific outcomes, such as the presence of biologically aggressive histopathological characteristics, that are associated with the subtypes of iron deficiency. The purpose of this study was to investigate the connection between the development of colorectal cancer and the presence of functional iron deficiency (FID), which is defined as insufficient biological availability of iron in the presence of adequate storage reserves, or absolute iron deficiency (AID), which is defined as severely depleted iron storage levels. Materials and Methods: Our paper represents a single center registry-based cohort study. Iron levels were routinely evaluated upon diagnosis of CRC and the collected data were coupled with patient- and tumor-specific data (2018–2022). Spearman's correlation coefficient and the chi-squared test were used to analyze the association. Results: Out of 129 patients, 75 (58.13%) were anemic. AID was identified in 26.35% of cases and FID was encountered in 51.16% of cases. A statistically significant association between FID and lymphatic invasion was encountered. An analysis of the correlation demonstrated a significant association between anemia and right-sided tumor location. Conclusions: Functional iron deficiency seems to be independently associated with lymphatic invasion. Although a statistically significant correlation with the T or N stage was not demonstrated, the analysis suggested a potential positive relationship between the presence of FID and more aggressive tumor characteristics. [ABSTRACT FROM AUTHOR]

The trace metal iron (Fe) is now routinely included in state-of-the-art ocean general circulation and biogeochemistry models (OGCBMs) because of its key role as a limiting nutrient in regions of the world ocean important for carbon cycling and air-sea CO2 exchange. However, the complexities of the seawater Fe cycle, which impact its speciation and bioavailability, are highly simplified in such OGCBMs to avoid high computational costs. In a similar fashion to inorganic carbon speciation, we outline a means by which the complex speciation of Fe can be included in global OGCBMs in a reasonably cost-effective manner. We use our Fe speciation to suggest the global distribution of different Fe species is tightly controlled by environmental variability (temperature, light, oxygen and pH) and the assumptions regarding Fe binding ligands. Impacts on bioavailable Fe are highly sensitive to assumptions regarding which Fe species are bioavailable. When forced by representations of future ocean circulation and climate we find large changes to the speciation of Fe governed by pH mediated changes to redox kinetics. We speculate that these changes may exert selective pressure on phytoplankton Fe uptake strategies in the future ocean. We hope our modeling approach can also be used as a "test bed" for exploring our understanding of Fe speciation at the global scale. [ABSTRACT FROM AUTHOR]

The White Sea of Russian Arctic is characterized by extreme diversity of enclosed estuarine systems that are often sites of unique biota. The present study focuses on surface sediments from representative restricted exchange environments of the inner part of Kandalaksha Bay, adjacent to the Karelian shore of the White Sea. The TOC and n-alkanes distribution study revealed the major input of terrestrial organic matter into the sediments from higher plants and minor presence of autochthonous microbial sources. Metal (Fe, Mn, Cu, Zn, Cr and Pb) forms study showed that metals in sediments occur mainly in a biogeochemically stable mineral-incorporated form, which comprises up to 98% of total metal content, while labile (acid soluble) and organically bound (alkali soluble) forms make up to 3-11% and 2-12% of total metal content, respectively. Presumably, the major part of both acid soluble and alkali soluble forms is comprised of metals associated with easily soluble amorphous Fe-oxides and bound to sediment organic matter. According to sediment quality guidelines, all trace-metal contents were below the threshold levels. Among sites studied, the heightened contents of bioavailable metal forms are related to sediments enriched in organic matter and/or located within the sea-fresh water barrier zones. The elements studied may be arranged in the following decreasing sequence according to their potential bioavailability: Cu>Zn>Mn>Fe>Cr>Pb. The present study can serve as a basis for comprehensive environmental assessment of the region and objective anoxia prognosis in Arctic ecosystems, while the role of microbial community in element speciation in sediments needs special attention. [ABSTRACT FROM AUTHOR]

This study reviews the application of nanotechnology and curcumin, a polyphenol extracted from turmeric, in treating digestive cancers, one of the most common types of malignancies worldwide. Despite curcumin's potential for inhibiting tumor growth, its clinical application is hindered by issues such as poor solubility and bioavailability. Nanomedicine, with its unique ability to enhance drug delivery and reduce toxicity, offers a solution to these limitations. The paper focuses on the development of nanoformulations of curcumin, such as nanoparticles and liposomes, that improve its bioavailability and efficacy in treating digestive cancers, including liver and colorectal cancers. The study serves as a valuable reference for future research and development in this promising therapeutic approach. This article reviews the burgeoning field of nanotechnology and its applications in anticancer therapeutics, particularly focusing on the utilization of curcumin nanoparticles for the treatment of digestive cancers. With the global rise in the prevalence of digestive cancer, there is an urgent need for newer, more efficient and less toxic therapeutic strategies. Curcumin, a compound derived from turmeric, has shown considerable promise due to its broad-spectrum anticancer properties; however, its clinical application has been limited, as it is not absorbed well by the body and is cleared quickly. Nanotechnology presents a potential solution to these challenges, allowing for the enhanced delivery and therapeutic effectiveness of curcumin. This review delves into the advancements made in the field of curcumin nanoparticle research and the results of preclinical and clinical studies, focusing on digestive cancers. In addition, the challenges encountered in the development and clinical implementation of curcumin nanoparticles are addressed and a perspective on future directions in this promising area of research is provided. By combining the age-old wisdom of curcumin's therapeutic potential with the cutting-edge technology of nanomedicine, this review aims to shed light on the evolution and prospects of a novel therapeutic modality against digestive cancers. Exploring the promising intersection of nanotechnology and curcumin in the battle against digestive cancers. Nanoformulations enhance curcumin's bioavailability, improving its efficacy in cancer therapy while reducing toxicity. #Nanomedicine #Curcumin [ABSTRACT FROM AUTHOR]

Macronutrients play a crucial role in management of type 2 diabetes. This is seen in their ability to modulate plasma glucose concentrations. However, the ideal proportions of macronutrients to be consumed in order to maintain ideal plasma glucose concentrations remains elusive. Therefore, this paper set out to conduct a review to investigate the relationship between macronutrients and plasma glucose concentrations from a physiological perspective. The review was conducted using papers obtained from various databases such as MEDLINE (Pubmed), Open Access Journals Elsevier, Free Medical Journals and Google Scholar. The research papers included general reviews, systemic reviews, meta-analyses, and randomized control trials that examined the effect of macronutrients on plasma glucose concentration as well as papers on mathematical models describing the relationship between macronutrient bioavailability and plasma glucose concentration. The review assessed the effect of various macronutrients on postprandial plasma glucose concentration, post-prandial plasma insulin, post-prandial glucose-dependent insulinotropic peptide plasma concentration, and post-prandial glucose-like peptide-1 plasma concentration. The results of the review showed that carbohydrates influence plasma glucose concentration in a dose dependant manner but this is dependent on their bioavailability. This bioavailability was shown to be subject to fluctuations determined by food processing techniques, food structure, and food matrix. The results also showed that some specific types of fats and proteins indirectly influence plasma glucose concentration through their effect on incretin hormones. The effect of fats and proteins on incretin hormones was through different mechanisms and pathways. In-lieu of the findings, the review concludes that the macronutrient composition of diets designed for type 2 diabetic patients should take into consideration the physiological relationship between the macronutrients and plasma glucose concentrations. In this way, diet proportions can be made in such a manner as to determine the exact amounts that will realize near normal plasma glucose concentrations for a type 2 diabetic patient. [ABSTRACT FROM AUTHOR]

Many bioactive substances have excellent functional properties, including anti-oxidation, anti-inflammatory, and anti-tumor; however, they are often susceptible to degradation by external factors such as light, heat, pH, and ionic strength. To improve stability and bioavailability, various methods have been developed to encapsulate bioactive substances. Emulsion approaches have shown excellent performance for the encapsulation, controlled release, and targeted delivery of bioactive substances. However, a single emulsification material is not sufficient to keep complex foods stable over a wide range of conditions of pH, storage time, and temperature. Improved food emulsions can be designed by combining emulsifiers with distinct properties to meet the range of necessary requirements. For example, the formation of multilayer interfaces around oil droplets, using layer-by-layer self-assembly in oil-in-water emulsions, can improve the quality and stability of many foods. This technology allows the gradual adsorption of various components, including polyelectrolytes, nanoparticles, proteins, and enzymes, and allows for the formation of a multilayer shell with nanometer thickness and high stability. This paper reviews latest developments in the preparation, characterization, and application of multilayer emulsion delivery systems for bioactive substances. Furthermore, we discuss next steps in the development of multilayer emulsions to achieve effective encapsulation and delivery of bioactive substances. [ABSTRACT FROM AUTHOR]

Copyright of Shipin Kexue/ Food Science is the property of Food Science Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In light of its potential health benefits, including as improved gut health and management of the gut microbiota, herbal extracts have witnessed a major increase in demand as prebiotics in recent years. Many studies have demonstrated that polyphenolrich herbal extracts can work as prebiotics by encouraging the growth of beneficial gut flora. Unfortunately, the limited solubility and stability of these herbal extracts, as well as their susceptibility to breakdown in the gastrointestinal system, can limited their bioavailability and efficiency. To address these limitations, the integration of metal nanoparticles has emerged as a promising strategy for the efficient delivery of herbal extracts, affording heightened bioavailability and precise targeting of the gut microbiota. In this paper, we present current breakthrough in metal infused nanoparticle-based assessment of herbal extracts as efficient prebiotics, with an emphasis on formulation, characterization, and biological activity. The integration of metal nanoparticles into polyphenol-rich herbal extracts represents a cutting-edge approach to enhancing the prebiotic properties of these compounds. Metal-infused polyphenol-enriched phyto-fabricated nanoparticles hold great promise for improving gut health and modulating the gut microbiota, offering innovative solutions to address the limitations associated with traditional polyphenol delivery. Furthermore, extracts of polyphenol-rich medicinal herbs such as rosehip flower, hibiscus flower, mango bark, bamboo stem, green tea, pomegranate, and dhataki flower have been investigated to assess the viability of employing these phyto generated metal infused nanoparticles as a potential prebiotic. [ABSTRACT FROM AUTHOR]

Diabetic kidney disease (DKD) is the primary cause of mortality among diabetic patients. With the increasing prevalence of diabetes, it has become a major concern around the world. The therapeutic effect of clinical use of drugs is far from expected, and therapy choices to slow the progression of DKD remain restricted. Therefore, research on new drugs and treatments for DKD has been a hot topic in the medical field. It has been found that rhein has the potential to target the pathogenesis of DKD and has a wide range of pharmacological effects on DKD, such as anti-nephritis, decreasing blood glucose, controlling blood lipids and renal protection. In recent years, the medical value of rhein in the treatment of diabetes, DKD and renal disease has gradually attracted worldwide attention, especially its potential in the treatment of DKD. Currently, DKD can only be treated with medications from a single symptom and are accompanied by adverse effects, while rhein improves DKD with a multi-pathway and multi-target approach. Therefore, this paper reviews the therapeutic effects of rhein on DKD, and proposes solutions to the limitations of rhein itself, in order to provide valuable references for the clinical application of rhein in DKD and the development of new drugs. [ABSTRACT FROM AUTHOR]

This paper describes the dynamics of 137Cs accumulation and its concentration ratio as well as that of some stable elements in the body, shell, gastrointestinal tract and albumin gland of a particular species of snail (terrestrial gastropod), namely the Giant African snail (Lissachatina fulica), after the long-term ingestion of contaminated forage and/or soil. The activity concentration of 137Cs in the their bodies increased over the first 40 days of the experiment, after which the increase in the activity of this radionuclide significantly reduced. The distribution of 137Cs in the body of a snail decreases as follows: gastrointestinal tract ˃ body = albumin gland ˃ shell. It was found that the contribution of soil towards the contamination of their bodies by 137Cs is far less than that of forage. Although the biological availability of Pb and U in forage is one order of magnitude higher than in soil, the main contribution to the contamination of snails originates from soil. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Henan University of Technology Natural Science Edition is the property of Henan University of Technology Journal Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Shenyang Pharmaceutical University is the property of Shenyang Pharmaceutical University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Researchers have been focusing on the potential of using plant polyphenols for promoting human health and have identified that the problems of poor stability, poor solubility, and low bioavailability of polyphenols in practical applications need to be urgently solved. The nanoemulsion delivery system has a small droplet size and good stability, thus is an excellent polyphenol delivery system with promising applications. Nanoemulsion-encapsulated polyphenols show improved stability, in vivo bioavailability, bioaccessibility, and antioxidant and antitumor activities, making it more suitable for application in the food industry. This paper reviews the current research on the classification and role of polyphenols, novel technologies for the preparation of polyphenol nanoemulsions, and the mechanism of nanoemulsion encapsulation and its effects on various properties of polyphenols. Based on the current problems posed when using polyphenol nanoemulsions, emulsion optimization scheme is proposed. Overall, the application status and potential use of polyphenol nanoemulsions in the food industry were explored. The findings of this study provide insights into future application directions of polyphenol nanoemulsions. [ABSTRACT FROM AUTHOR]

There is a connection between bioavailability and absorption. In the field of pharmacology, this is referred to as a category of absorption and is defined as the proportion of a particular dosage of a drug that does not change and is absorbed into the systemic circulation. Both the overall absorption of medications and their specific bioavailability are important factors to consider in treatment. In this paper, we will go into great detail about the bioavailability of phytochemicals. We will also discuss the factors that influence bioavailability, the processes that improve bioavailability, and the phytochemicals that act as important bio enhancers, which are agents that improve the bioavailability of drugs. [ABSTRACT FROM AUTHOR]

Studies conducted in the past few years have found that the intestinal environment of insect larvae, including mealworms (Tenebrio molitor), is a microenvironment suitable for rapid plastic biodegradation. However, researchers have focused more attention on the study of the gut microbiome, and this separation of the gut microbiome from the insect body has led to a lack of knowledge of the insect gut microenvironment. In this paper, it was demonstrated that the intestinal supernatant of mealworms can act as a surfactant to enhance the hydrophilicity of polyethylene and promote the growth of intestinal microorganisms to further improve the bioavailability of polyethylene (PE). Five unique intestinal microorganisms associated with PE biodegradation, including Spiroplasma, Lactococcus, Enterococcus, were identified by high-throughput sequencing technology. The experimental results showed the existence of a cooperative relationship between the mealworms themselves and their gut microbiome. And through this synergy, the biodegradation efficiency of plastics is enhanced. This work provides new insights into the mechanisms of insect-mediated plastic degradation and offers a potential strategy for future research and large-scale cultivation of plastic-degrading microorganisms. [ABSTRACT FROM AUTHOR]

In recent years, there has been considerable interest in icariin (ICA) and its derivates, icariside II (ICS) and icaritin (ICT), due to their wide range of potential applications in preventing cancer, cardiovascular disease, osteoporosis, delaying the effects of Alzheimer's disease, treating erectile dysfunction, etc. However, their poor water solubility and membrane permeability, resulting in low bioavailability, dampens their potential beneficial effects. In this regard, several strategies have been developed, such as pharmaceutical technologies, structural transformations, and absorption enhancers. All these strategies manage to improve the bioavailability of the above-mentioned flavonoids, thus increasing their concentration in the desired places. This paper focuses on gathering the latest knowledge on strategies to improve bioavailability for enhancing the efficacy of icariin, icariside II, and icaritin. We conclude that there is an opportunity for many further improvements in this field. To the best of our knowledge, no such review articles scoping the bioavailability improvement of icariin and its derivates have been published to date. Therefore, this paper can be a good starting point for all those who want to deepen their understanding of the field. [ABSTRACT FROM AUTHOR]

Cancer has been a serious public health problem. Berberine is a famous natural compound from medicinal herbs and shows many bioactivities, such as antioxidant, anti-inflammatory, antidiabetic, anti-obesity, and antimicrobial activities. In addition, berberine shows anticancer effects on a variety of cancers, such as breast, lung, gastric, liver, colorectal, ovarian, cervical, and prostate cancers. The underlying mechanisms of action include inhibiting cancer cell proliferation, suppressing metastasis, inducing apoptosis, activating autophagy, regulating gut microbiota, and improving the effects of anticancer drugs. This paper summarizes effectiveness and mechanisms of berberine on different cancers and highlights the mechanisms of action. In addition, the nanotechnologies to improve bioavailability of berberine are included. Moreover, the side effects of berberine are also discussed. This paper is helpful for the prevention and treatment of cancers using berberine. [ABSTRACT FROM AUTHOR]

Copyright of Food Research & Development is the property of Food Research & Development Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

AbstractDietary flavonoids exhibit a variety of physiological functions in regulating glucose and lipid metabolism, improving cardiovascular function, and enhancing stress resistance. However, poor intestinal absorption limits their health benefits. Previous studies on improving the absorption efficiency of flavonoids have focused on targeted release, enhanced gastrointestinal stability and prolonged retention time in digestive tract. But less attention has been paid to promoting the uptake and transport of flavonoids by intestinal epithelial cells through modulation of transporter protein-mediated pathways. Interestingly, some dietary nutrients have been found to modulate the expression or function of transporter proteins, thereby synergistically or antagonistically affecting flavonoid absorption. Therefore, this paper proposed an innovative regulatory strategy known as the "intestinal transport protein-mediated pathway" to promote intestinal absorption of dietary flavonoids. The flavonoid absorption mechanism in the intestinal epithelium, mediated by intestinal transport proteins, was summarized. The functional differences between the uptake transporter and efflux transporters during flavonoid trans-intestinal cellular transport were discussed. Finally, from the perspective of nutritional synergy promotion of absorption, the feasibility of promoting flavonoid intestinal absorption by regulating the expression/function of transport proteins through dietary nutrients was emphasized. This review provides a new perspective and developing precise dietary nutrient combinations for efficient dietary flavonoid absorption. [ABSTRACT FROM AUTHOR]

In situ gelling systems represent a burgeoning paradigm in ocular drug administration, addressing intrinsic challenges posed by extant ocular formulations, such as compromised bioavailability and constraints in traversing the corneal barrier. This systematic review endeavours to comprehensively examine the contemporary landscape of research in this domain, focusing on the nuanced capabilities of in situ gelling systems to optimize drug delivery and enhance therapeutic outcomes, without much technological complexity. Employing a meticulous search strategy across diverse databases for publications and patents spanning the years 2015 to 2023 a total of 26 research papers and 14 patents meeting stringent inclusion criteria were identified. Synthesizing the collective insights derived from these investigations, it becomes evident that in situ gelling systems confer an ability to protract the residence time of formulations or active pharmaceutical ingredients (APIs) within the ocular milieu. This sustained presence engenders extended drug release kinetics, thereby fostering improved patient compliance and mitigating the proclivity for side effects attendant to frequent dosing. These salutary effects extend to diminished systemic drug absorption, augmented ocular bioavailability, and the prospect of reduced dosing frequencies, thereby amplifying patient adherence to therapeutic regimens. Intriguingly, the protective attributes of in situ gelling systems extend to the establishment of an ocular surface barrier, thereby abating the susceptibility to infections and inflammatory responses. In summation, this review underscores the auspicious potential of in situ gelling systems as a transformative approach to advancing ocular drug delivery, warranting sustained research endeavours and developmental initiatives for the betterment of global patient outcomes. [Display omitted] • In situ gels for ocular delivery offer simple alternative to conventional low performing drops • Various polymer and polymer combinations are used for in situ gelling, each with distinct mechanism and advantages. • Gelling upon application enhances drug retention and improves ocular bioavailability. • In situ gel-forming systems represent advanced ocular drug delivery, with enhanced therapeutic outcomes for eye disorders. • This review covers recent research and patents, focusing on ophthalmic applications of in situ gels. [ABSTRACT FROM AUTHOR]

Lycopene is a promising biological functional component with various biological activities and excellent pharmacological activities. However, its low water solubility and stability lead to low oral bioavailability, which limits its edible and medicinal research. Then, it is necessary to explore effective methods to protect lycopene from destruction and further exploit its potential benefits. The absorption of lycopene in vivo is affected by solubility, stability, isomer type, emulsifying ability, difficulty in forming micelles in vivo, and interaction with food components. Emulsions, pickering emulsions, micelles, liposomes, bigels, beasds, solid dispersions, microcapsules, nanoparticles, electrospinning and other drug delivery systems can be used as good strategies to improve the stability and bioavailability of lycopene. In this paper, the absorption process of lycopene in vivo and the factors affecting its bioavailability were discussed, and the preparation strategies for improving the stability, bioavailability, and health benefits of lycopene were reviewed, to provide some clues and references for the full utilization of lycopene in the field of health. However, there are still various unresolved mysteries regarding the metabolism of lycopene. The safety and in vivo studies of various preparations should be further explored, and the above technologies also face the challenge of industrial production. [ABSTRACT FROM AUTHOR]

Anthropogenic activities have caused irreversible consequences on our planet, including climate change and environmental pollution. Nevertheless, reducing greenhouse gas (GHG) emissions and capturing carbon can mitigate global warming. Biochar and hydrochar are increasingly used for soil remediation due to their stable adsorption qualities. As soil amendments, these materials improve soil quality and reduce water loss, prevent cracking and shrinkage, and interact with microbial communities, resulting in a promising treatment method for reducing gas emissions from the top layer of soil. However, during long-term studies, contradictory results were found, suggesting that higher biochar application rates led to higher soil CO2 effluxes, biodiversity loss, an increase in invasive species, and changes in nutrient cycling. Hydrochar, generated through hydrothermal carbonization, might be less stable when introduced into the soil, which could lead to heightened GHG emissions due to quicker carbon breakdown and increased microbial activity. On the other hand, biochar, created via pyrolysis, demonstrates stability and can beneficially impact GHG emissions. Biochar could be the preferred red option for carbon sequestration purposes, while hydrochar might be more advantageous for use as a gas adsorbent. This review paper highlights the ecological impact of long-term applications of biochar and hydrochar in soil. In general, using these materials as soil amendments helps establish a sustainable pool of organic carbon, decreasing atmospheric GHG concentration and mitigating the impacts of climate change. [ABSTRACT FROM AUTHOR]

The document "Enhancing the Bioavailability of Poorly Soluble Drugs" explores the challenges posed by drugs with poor solubility and the ongoing efforts to improve their absorption and bioavailability. It discusses various strategies and advancements in formulation, processing, and screening techniques, such as amorphous formulations, self-emulsifying systems, lipid-based formulations, and nanoparticle-based systems. The document emphasizes the multidisciplinary efforts of pharmaceutical scientists to advance pharmaceutical product development and improve drug solubility. It is a compilation of research papers by various authors in the field of pharmaceutics, covering topics like drug formulation, solubility enhancement, drug delivery systems, and bioavailability improvement. The aim of these contributions is to advance drug product development and ultimately improve patient outcomes. [Extracted from the article]

Regeneration is a complex process affected by many elements independent or combined, including inflammation, proliferation, and tissue remodeling. Stem cells is a class of primitive cells with the potentiality of differentiation, regenerate with self‐replication, multidirectional differentiation, and immunomodulatory functions. Stem cells and their cytokines not only inextricably linked to the regeneration of ectodermal and skin tissues, but also can be used for the treatment of a variety of chronic wounds. Stem cells can produce exosomes in a paracrine manner. Stem cell exosomes play an important role in tissue regeneration, repair, and accelerated wound healing, the biological properties of which are similar with stem cells, while stem cell exosomes are safer and more effective. Skin and bone tissues are critical organs in the body, which are essential for sustaining life activities. The weak repairing ability leads a pronounced impact on the quality of life of patients, which could be alleviated by stem cell exosomes treatment. However, there are obstacles that stem cells and stem cells exosomes trough skin for improved bioavailability. This paper summarizes the applications and mechanisms of stem cells and stem cells exosomes for skin and bone healing. We also propose new ways of utilizing stem cells and their exosomes through different nanoformulations, liposomes and nanoliposomes, polymer micelles, microspheres, hydrogels, and scaffold microneedles, to improve their use in tissue healing and regeneration. [ABSTRACT FROM AUTHOR]

Copyright of Feed Research is the property of Editorial Board of Feed Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Pesticide Science / Nongyaoxue Xuebao is the property of Chinese Journal of Pesticide Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Micronutrient deficiency still occurs in sub‐Saharan Africa (SSA) despite the availability of several food resources, particularly fermented foods and vegetables, with high nutritional potential. Fermentation enhances the quality of food in several aspects. Organoleptically, certain taste, aroma, and textures are developed. Health and safety are improved by inhibiting the growth of several foodborne pathogens and removing harmful toxic compounds. Furthermore, nutrition is enhanced by improving micronutrient contents and bioavailability from the food, especially vitamin B content. However, during processing and before final consumption, many fermented foods are heat treated (drying, pasteurization, cooking, etc.) to make the food digestible and safe for consumption. Heat treatment improves the bioavailability of B‐vitamins in some foods. In other foods, heating decreases the nutritional value because some B‐vitamins are degraded. In SSA, cooked starchy foods are often associated with vegetables in household meals. This paper reviews studies that have focused fermented starchy foods and vegetable foods in SSA with the potential to provide B‐vitamins to consumers. The review also describes the process of the preparation of these foods for final consumption, and techniques that can prevent or lessen B‐vitamin loss, or enrich B‐vitamins prior to consumption. [ABSTRACT FROM AUTHOR]

Simple Summary: Crucian carp (Carassius auratus) is a freshwater fish that is popular due to its high nutritional value and delicious taste. It has become one of the most commonly farmed fish species, particularly in China. With the rapid development of intensive aquaculture, fish are becoming increasingly vulnerable to various pathogens that can cause significant economic losses. To reduce these losses, treatment with effective antibacterials is necessary. Although not approved in China, difloxacin is being used extensively in an extra-label manner to treat infections in aquaculture. However, the dosage guidelines specific to fish have not been established, resulting in the extrapolation of mammalian dosing regimens. Because fish are poikilotherms with unique physiologies and anatomies, dosing regimens intended for mammals may not be appropriate for them. In this research paper, we have employed a sparse sampling method and non-linear mixed effect modeling to develop population pharmacokinetics models. In addition, we have determined the values of the PK/PD parameter (free AUC/MIC) by utilizing previously published MIC data. Based on the free AUC/MIC values calculated herein, the current oral dose of difloxacin (20 mg/kg body weight) might be not enough to treat infections in crucian carp. This study aimed to investigate the population pharmacokinetics of difloxacin in crucian carp (Carassius auratus) orally provided a single dose of 20 mg/kg body weight (BW). To achieve this, fish were sampled at various intervals using a sparse sampling strategy, and plasma samples were analyzed using the high-performance liquid chromatography (HPLC) method. Subsequently, naïve average data were analyzed using a non-compartmental method, and a population model was developed based on the nonlinear mixed effects approach. The covariate of BW and the relationship between covariances were sequentially incorporated into the population model. However, it was found that only covariance and not BW affected the population parameters. Therefore, the covariance model was taken as the final population model, which revealed that the typical values of the absorption rate constant (tvKa), apparent volume of distribution per bioavailability (tvV), and clearance rate per bioavailability (tvCl) were 1.18 1/h, 14.18 L/kg, and 0.20 L/h/kg, respectively. Based on the calculated free AUC/MIC values, the current oral dose of difloxacin (20 mg/kg BW) cannot generate adequate plasma concentrations to inhibit pathogens with MIC values above 0.83 μg/mL. Further study should be carried out to collect the pathogens from crucian carp and determine the MIC data of difloxacin against them. Pharmacodynamic experiments must also be further carried out to determine the optimal therapeutic dose for the treatment of Aeromonas hydrophila infection. [ABSTRACT FROM AUTHOR]

Introduction: Parenteral administration of gentamicin is a globally known therapeutic strategy for severe infections, including severe community acquired pneumonia, complex severe acute malnourishment, neonatal and pediatric sepsis. The drug is also prescribed as an ophthalmologic anti-infective. In most cases, the therapeutic course necessitates frequent bolus medication doses, lengthy hospitalization, and ongoing therapeutic monitoring; hence a qualified healthcare provider is required. Objectives: Gentamicin is a hydrophilic drug and has a short half-life, making it difficult to achieve appropriate systemic concentrations when taken parenterally. The use of innovative oral medication delivery systems is justified in this context. Furthermore, new delivery strategies can increase the membrane permeability of gentamicin. Conclusion: The current analysis provides a detailed summary of gentamicin's research history as well as several developing drug delivery strategies that have been explored. The examples included in the paper give important evidence on innovative delivery systems for gentamicin in the domain of antimicrobial investigations opening a way for upcoming therapeutics that may provide better clinical outcomes. [ABSTRACT FROM AUTHOR]

Copyright of Feed Research is the property of Editorial Board of Feed Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In recent years, plant polyphenols have become a popular focus for the development of novel functional foods. Polyphenols, a class of bioactive compounds, including flavonoids, phenolic acids, and lignans, are commonly found in plant-based diets with a variety of biological actions, including antioxidant, anti-inflammatory, and anticancer effects. Unfortunately, polyphenols are not widely used in nutraceuticals since many of the chemicals in polyphenols possess poor oral bioavailability. Thankfully, polyphenols can be encapsulated and transported using bio-based nanocarriers, thereby increasing their bioavailability. Polyphenols' limited water solubility and low bioavailability are limiting factors for their practical usage, but this issue can be resolved if suitable delivery vehicles are developed for encapsulating and delivering polyphenolic compounds. This paper provides an overview of the study of nanocarriers for the enhancement of polyphenol oral bioavailability, as well as a summary of the health advantages of polyphenols in the prevention and treatment of several diseases. [ABSTRACT FROM AUTHOR]

Traditional Chinese medicine (TCM) has been used for centuries to prevent and treat a variety of illnesses, and its popularity is increasing worldwide. However, the clinical applications of natural active components in TCM are hindered by the poor solubility and low bioavailability of these compounds. To address these issues, Chinese medicine self-assembly nanostrategy (CSAN) is being developed. Many active components of TCM possess self-assembly properties, allowing them to form nanoparticles (NPs) through various noncovalent forces. Self-assembled NPs (SANs) are also present in TCM decoctions, and they are closely linked to the therapeutic effects of these remedies. SAN is gaining popularity in the nano research field due to its simplicity, eco-friendliness, and enhanced biodegradability and biocompatibility compared to traditional nano preparation methods. The self-assembly of active ingredients from TCM that exhibit antitumour effects or are combined with other antitumour drugs has generated considerable interest in the field of cancer therapeutics. This paper provides a review of the principles and forms of CSAN, as well as an overview of recent reports on TCM that can be used for self-assembly. Additionally, the application of CSAN in various cancer diseases is summarized, and finally, a concluding summary and thoughts are proposed. We strongly believe that CSAN has the potential to offer fresh strategies and perspectives for the modernization of TCM. [ABSTRACT FROM AUTHOR]

Copyright of Asian Journals of Ecotoxicology is the property of Gai Kan Bian Wei Hui and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Salts of active pharmaceutical components are made to improve the parent drug's solubility and bioavailability. The synthesis and characterization of mycophenolic acid salt are presented in this paper. Mycophenolic acid is a BCS class 2 drug used as a potential immune-suppressing agent. It has potential uses but has solubility issues; converting to salt form can increase solubility and help in formulation development. Thermal methods such as Differential Scanning Calorimetry (DSC), Thermogravimetry, and other methods such as Fourier Transform Infrared Spectroscopy and Powder X-ray Diffraction were used to analyze the produced salt. The DSC curves of the parent drug and its isobutanolammonium salt vary, indicating that the drug and the salt former had undergone a chemical interaction. According to powder X-ray diffraction analysis, the product generated from the reaction was salt, not the parent drug's cocrystal. The salt produced is unreported and has high solubility over the available options. The salt is dissolved at intestinal pH as inferred from the in vitro simulated dissolution experiment, which is an added advantage over the available counterparts. Moreover, the procedure reported is important in drug development and will help researchers with further formulation and development studies. [ABSTRACT FROM AUTHOR]

Copyright of Shipin Kexue/ Food Science is the property of Food Science Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Emerging evidence suggests that cognitive impairments may result from various factors, such as neuroinflammation, oxidative stress, mitochondrial damage, impaired neurogenesis, synaptic plasticity, blood–brain barrier (BBB) disruption, amyloid β protein (Aβ) deposition, and gut dysbiosis. Meanwhile, dietary polyphenol intake in a recommended dosage has been suggested to reverse cognitive dysfunction via various pathways. However, excessive intake of polyphenols could trigger unwanted adverse effects. Thus, this review aims to outline possible causes of cognitive impairments and how polyphenols alleviate memory loss via various pathways based on in vivo experimental studies. Thus, to identify potentially relevant articles, the keywords (1) nutritional polyphenol intervention NOT medicine AND neuron growth OR (2) dietary polyphenol AND neurogenesis AND memory impairment OR (3) polyphenol AND neuron regeneration AND memory deterioration (Boolean operators) were used in the Nature, PubMed, Scopus, and Wiley online libraries. Based on the inclusion and exclusion criteria, 36 research papers were selected to be further reviewed. The outcome of all the studies included supports the statement of appropriate dosage by taking into consideration gender differences, underlying conditions, lifestyle, and causative factors for cognitive decline, which will significantly boost memory power. Therefore, this review recapitulates the possible causes of cognitive decline, the mechanism of polyphenols involving various signaling pathways in modulating the memory, gut dysbiosis, endogenous antioxidants, bioavailability, dosage, and safety efficacy of polyphenols. Hence, this review is expected to provide a basic understanding of therapeutic development for cognitive impairments in the future. [ABSTRACT FROM AUTHOR]

Copyright of Shipin Kexue/ Food Science is the property of Food Science Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In the development of new drugs products, especially the development of traditional Chinese medicine active ingredients, solubility and oral bioavailability are the main factors which are restricting the development of new drugs, whereas the physicochemical properties of active ingredients are the key element to affecting these factors. Pharmaceutical cocrystal provides an excellent opportunity to develop new drugs with excellent physical and chemical properties such as melting point, solubility, stability and bioavailability while retaining the pharmacological properties of individuals active pharmaceutical ingredients among pharmaceutical cocrystal compounds. Traditional Chinese herbal medicine has the characteristics of multiple pathways and multiple targets, mainly because it contains many active ingredients, like cocrystals thereof with many components. The active ingredients extracted from traditional Chinese herbal medicine have a wide range of pharmacological activities, but most of the active ingredients affect the development of traditional Chinese medicine active ingredients due to their physical and chemical properties such as solubility. Traditional Chinese medicine pharmaceutical cocrystals can not only improve the physical and chemical properties of drugs without changing the internal structure of drugs, so as to provide a new scheme for the development of traditional Chinese medicine active ingredients. This paper reviews the research progress of active ingredients of traditional Chinese medicine pharmaceutical cocrystal. The preparation methods of cocrystals are summarized and the advantages of cocrystals are illustrated with examples. [ABSTRACT FROM AUTHOR]

The anti-inflammatory drugs that are generally available possess the disadvantage of hydrophobicity, which leads to poor permeability and erratic bioavailability. Nanoemulgels (NEGs) are novel drug delivery systems that aim to improve the solubility and permeability of drugs across the biological membrane. The nano-sized droplets in the nanoemulsion enhance the permeation of the formulation, along with surfactants and co-surfactants that act as permeation enhancers and can further improve permeability. The hydrogel component of NEG helps to increase the viscosity and spreadability of the formulation, making it ideal for topical application. Moreover, oils that have anti-inflammatory properties, such as eucalyptus oil, emu oil and clove oil, are used as oil phases in the preparation of the nanoemulsion, which shows a synergistic effect with active moiety and enhances its overall therapeutic profile. This leads to the creation of hydrophobic drugs that possess enhanced pharmacokinetic and pharmacodynamic properties, and simultaneously avoid systemic side effects in individuals with external inflammatory disorders. The nanoemulsion's effective spreadability, ease of application, non-invasive administration, and subsequent ability to achieve patient compliance make it more suitable for topical application in the combat of many inflammatory disorders, such as dermatitis, psoriasis, rheumatoid arthritis, osteoarthritis and so on. Although the large-scale practical application of NEG is limited due to problems regarding its scalability and thermodynamic instability, which arise from the use of high-energy approaches during the production of the nanoemulsion, these can be resolved by the advancement of an alternative nanoemulsification technique. Considering the potential advantages and long-term benefits of NEGs, the authors of this paper have compiled a review that elaborates the potential significance of utilizing nanoemulgels in a topical delivery system for anti-inflammatory drugs. [ABSTRACT FROM AUTHOR]

Polyphenols are plant-based compounds famous for their positive impact on both human health and the quality of food products. The benefits of polyphenols are related to reducing cardiovascular diseases, cholesterol management, cancers, and neurological disorders in humans and increasing the shelf life, management of oxidation, and anti-microbial activity in food products. The bioavailability and bio-accessibility of polyphenols are of the highest importance to secure their impact on human and food health. This paper summarizes the current state-of-the-art approaches on how polyphenols can be made more accessible in food products to contribute to human health. For example, by using food processing methods including various technologies, such as chemical and biotechnological treatments. Food matrix design and simulation procedures, in combination with encapsulation of fractionated polyphenols utilizing enzymatic and fermentation methodology, may be the future technologies to tailor specific food products with the ability to ensure polyphenol release and availability in the most suitable parts of the human body (bowl, intestine, etc.). The development of such new procedures for utilizing polyphenols, combining novel methodologies with traditional food processing technologies, has the potential to contribute enormous benefits to the food industry and health sector, not only reducing food waste and food-borne illnesses but also to sustain human health. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Food Safety & Quality is the property of Journal of Food Safety & Quality Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In this paper, lutein block polyethylene glycol (lutein-b-PEG) copolymers were synthesized by hydrophilic modification of lutein with carboxylated polyethylene glycol (CT-PEG). The unreacted lutein was loaded into micelles formed by self-assembly of block copolymers to prepare composite nanoparticles. The results of FT-IR, 1H NMR, gel permeation chromatography (GPC), UV–vis and critical micellar concentration (CMC) showed that the double terminal carboxyl group ratio of CT-PEG reached 50.31%, and lutein-b-PEG was successfully synthesized without destroying the structure of lutein. Compared with lutein, the retention rate of lutein composite nanoparticles increased from 4.32 to 81.3% after 30 days of storage in the dark. In addition, the saturation solubility and bioaccessibility of lutein nanoparticles were increased 35 times and 5.2 times, respectively, due to micellar formation and improved water solubility. These findings indicated that the lutein composite nanoparticles modified with PEG significantly improved the chemical stability, water solubility, and bioaccessibility of lutein. [ABSTRACT FROM AUTHOR]

Purpose: Straw return is a common agronomic practice for improving soil fertility and sustaining crop productivity. This paper considers the potential impacts of contaminated straw return on the availability of metal(loid)s and on microbial activity in paddy soils. Methods: Cadmium (Cd) and arsenic (As) co-contaminated soils were collected and incorporated with contaminated rice straw (RS) or coupled with straw-decomposing microbial inoculants (SD), and were incubated for 75 days under laboratory-controlled conditions. Results: The results showed that addition of straws (both RS and SD) increased soil total Cd and As concentrations by 0.07–0.11 and 1.83–1.89 mg·kg−1, respectively. In contrast to the control treatment (no straws, CK), RS and SD treatments significantly increased soil-available As concentrations throughout the incubation period, whereas available Cd concentrations decreased from day 10 to day 45. A remarkable rise in all Cd fractions was observed in the straw-applied treatments compared with CK. The easily soluble, Ca-associated and residual fractions of As were decreased and changed into Al-associated and Fe-oxyhydroxides As fractions. Compared with RS treatment, applying SDMIs accelerated the decomposition process of the straw and the transformation of Cd and As, and increased the richness and diversity of the bacterial community. Based on redundancy analysis, pH and dissolved organic carbon (DOC) were identified as the most important controlling factors for redistribution of Cd and As fractions during straw decomposition. Conclusions: These results highlight that we should be cautious when returning co-contaminated rice straw to paddy fields, as this practice may increase the risk of more As production. SDMI utilization is an effective strategy to immobilize Cd, but it may enhance the availability of As. [ABSTRACT FROM AUTHOR]

Phenolic acids (PAs), a class of small bioactive molecules widely distributed in food and mainly found as secondary plant metabolites, present significant advantages such as antioxidant activity and other health benefits. The global epidemic of nonalcoholic fatty liver disease (NAFLD) is becoming a serious public health problem. Existing studies showed that gut microbiota (GM) dysbiosis is highly associated with the occurrence and development of NAFLD. In recent years, progress has been made in the study of the relationship among PA compounds, GM, and NAFLD. PAs can regulate the composition and functions of the GM to promote human health, while GM can increase the dietary sources of PAs and improve its bioavailability. This paper discussed PAs, GM, and their interrelationship while introducing several representative dietary PA sources and examining the absorption and metabolism of PAs mediated by GM. It also summarizes the effect and mechanisms of PAs in improving and regulating NAFLD via GM and their metabolites. This helps to better evaluate the potential preventive effect of PAs on NAFLD via the regulation of GM and expands the utilization of PAs and PA‐rich food resources. [ABSTRACT FROM AUTHOR]

Clarithromycin is a semi-synthetic macrolide antibiotic, chemically 6-0-methylerythromycin, formulated as immediate-release tablets, extended-release tablets, and granules for oral suspension. The objective of this study was to evaluate and compare the relative bioavailability, and therefore the bioequivalence of Clarithromycin 500 mg test formulation versus a reference Klacid ® forte 500 mg formulation, following a single dose administration under fasting conditions. The study was a single center, open, single dose, randomized, two-way crossover study in healthy male volunteers, with a wash-out period of one week between study periods. Twenty-four male healthy volunteers, aged 18-49 years were included into study. Blood samples for determination of clarithromycin and 14-OH clarithromycin concentrations were withdrawn at zero (pre-drug administration), 0.33, 0.66, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, 24 and 36 hours post-drug administration. The determination of clarithromycin and 14-OH clarithromycin concentrations in plasma was performed using validated LC/MS/MS method and internal standardization after liquid/liquid extraction with methyl t-butyl ether. The test formulation of clarithromycin, dosed at 500 mg is bioequivalent for primary clarithromycin and 14-OH clarithromycin parameters (Cmax, AUC0-t and AUC0-∞) to the reference formulation after a single oral administration of 500 mg clarithromycin. Both medications were well tolerated with no serious adverse events. Thus, in view of the clinical use, both formulations are exchangeable without restrictions. [ABSTRACT FROM AUTHOR]

Copyright of Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten is the property of Macedonian Pharmaceutical Association and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)